Evidence map›Paper›PMID 40267042›Full record

ArticleJournal of correctional health care : the official journal of the National Commission on Correctional Health Care2025

Pilot of Methadone for Recently Incarcerated People with Human Immunodeficiency Virus and Opioid Use in South Africa.

Urvisha Bhoora, Yangxi An, Jill Owczarzak, Pretty Ndini, Derrick Moyo, Shaun Shelly, Tessa S Marcus, Laura Steiner, Peter C Corcoran, Sarah Pollock and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of correctional health care : the official journal of the National Commission on Correctional Health Care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Urvisha BhooraDepartment of Family Medicine, University of Pretoria, Tshwane, South Africa.ORCID 0000-0002-2103-9858
Yangxi AnDepartment of Public Health Studies, Krieger School for the Arts and Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Jill OwczarzakDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pretty NdiniAurum Institute, Johannesburg, South Africa.ORCID 0009-0006-9321-6100
Derrick MoyoAurum Institute, Johannesburg, South Africa.
Shaun ShellyCommunity Oriented Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Tshwane, South Africa.
Tessa S MarcusDepartment of Family Medicine, University of Pretoria, Tshwane, South Africa.
Laura SteinerDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Peter C CorcoranDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sarah PollockDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Moganki H LefokaDepartment of Family Medicine, University of Pretoria, Tshwane, South Africa.
Tonderai MabutoAurum Institute, Johannesburg, South Africa.
Jannie HugoDepartment of Family Medicine, University of Pretoria, Tshwane, South Africa.
Christopher J HoffmannDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-9422-0519

Funding

Characterizing medication-assisted opioid use treatment and HIV care delivery for community re-entrants with HIV and opioid use disorder in South AfricaR21TW011689 · FIC · JOHNS HOPKINS UNIVERSITY · PI HOFFMANN, CHRISTOPHER J · 2020 to 2021
$366k
FIC NIH HHS R21 TW011689
6 · The paper itself

Abstract

In South Africa, there is no provision of medication for opioid use disorder (MOUD) for people who are incarcerated or were recently incarcerated. This study aimed to describe MOUD uptake and barriers among people living with human immunodeficiency virus and using illicit opioids reentering the community from incarceration. A mixed-method exploratory study was conducted between September 2021 and September 2022 in South Africa, during which we offered low-barrier MOUD and harm reduction services. We followed 23 participants postrelease and observed a low uptake of MOUD after release (8 of 23, 35%). Reported barriers to MOUD included perceived ineffectiveness, a preference for residential withdrawal management, and delays in initiating MOUD. Innovation is needed in strategies to deliver MOUD and harm reduction in South Africa.

Indexed as

HIV InfectionsMethadoneOpiate Substitution TreatmentOpioid-Related DisordersPrisonersAdultAnalgesics, OpioidFemaleHarm ReductionHumansMaleMiddle AgedPilot ProjectsSouth AfricaAnalgesics, OpioidMethadonecorrectional facilitiescorrectional health careHIVmethadoneopioid useSouth Africa

Identifiers

PMID40267042
PMCPMC13089407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.